Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.605
Delayed Data
As of Jul 02
 -0.006 / -0.98%
Today’s Change
0.60
Today|||52-Week Range
0.96
-13.57%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.61
Today’s open0.62
Day’s range0.61 - 0.64
Volume283,847
Average volume (3 months)603,255
Market cap$108.4M
Dividend yield--
Data as of 4:01pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.06

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...-0.52-5.07%
REPHRecro Pharma Inc+0.79+6.11%
AKAOAchaogen Inc-0.21-3.47%
AXNAoxing Pharmaceutica...+0.01+0.63%
Data as of 4:02pm ET, 07/02/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
President &
Chief Operating Officer
Rakesh Soni
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers